Search

Your search keyword '"Sellke FW"' showing total 616 results

Search Constraints

Start Over You searched for: Author "Sellke FW" Remove constraint Author: "Sellke FW"
616 results on '"Sellke FW"'

Search Results

1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

2. The urgent need for integrated science to fight COVID-19 pandemic and beyond

3. Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial

9. Myocardial therapeutic angiogenesis: a review of the state of development and future obstacles.

17. CaMKIIT287 and T305 regulate history-dependent increases in α agonist–induced vascular tone

34. Sodium-Glucose Cotransporter-2 Inhibition Normalizes Metabolic Derangements in the Ischemic Myocardium.

35. Metformin Preconditioning Augments Cardiac Perfusion and Performance in a Large Animal Model of Chronic Coronary Artery Disease.

36. Gender, Race, and Ethnicity in Lung Cancer Clinical Trial Participation: Analysis of 253,845 Patients From 2002 - 2021.

37. Coronary Microvascular Dysfunction: A Guide for Clinicians.

38. Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease.

39. Patients with uncontrolled hypertension subjected to cardiopulmonary bypass have altered coronary vasomotor responses to serotonin.

40. Cardioprotection in cardiovascular surgery.

41. Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia.

42. Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass.

43. Intramyocardial injection of hypoxia-conditioned extracellular vesicles increases myocardial perfusion in a swine model of chronic coronary disease.

44. Effects of diet-induced metabolic syndrome on cardiac function and angiogenesis in response to the sodium-glucose cotransporter-2 inhibitor canagliflozin.

45. Proteomic Analysis and Sex-Specific Changes in Chronically Ischemic Swine Myocardium Treated with Sodium-Glucose Cotransporter-2 Inhibitor Canagliflozin.

47. Gastrointestinal complications after cardiac surgery.

48. Proteomic Profiling of SGLT-2 Inhibitor Canagliflozin in a Swine Model of Chronic Myocardial Ischemia.

49. History of Psychoactive Medication a Risk Factor for Neurocognitive Decline After Cardiac Surgery.

50. DPP-4 inhibitor sitagliptin treatment results in altered myocardial metabolic proteome and oxidative phosphorylation in a swine model of chronic myocardial ischemia.

Catalog

Books, media, physical & digital resources